3186. PCR. HPV HCR 14 (cobas HPV FDA approved). Genotyping 16 and 18 and groups 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 (u/g scrape, qualitative)
Turnaround time (days): 3
1000 ₴
Important information
*FOR WOMEN ONLY
*The service can be ordered independently or as an add-on within 14 days from the date of ordering services 4276; 4281; 4282,4273,4041
Description
Screening test for detecting 14 high-risk human papillomavirus (HPV) genotypes. Performed by real-time PCR on the Cobas® platform (FDA approved).
Provides individual genotyping for HPV 16 and 18 and pooled detection of 12 other high-risk types, in accordance with Order No. 1057 of the Ministry of Health of Ukraine (June 18, 2024).
When and who needs the test?
- primary screening in women aged 25 and older, once every 5 years (according to MOH Order No. 1057);
- women with abnormal Pap test results (ASC-US, LSIL, HSIL);
- suspected HPV-associated cervical changes;
- co-testing (Pap + HPV test) – the recommended modern screening approach.
Biological material
- Site-specific scrapings collected depending on the test
Preparation for cytology
- Collect the material before starting treatment with antibacterial/antifungal drugs (general and local action).
- In case of treatment monitoring – 14 days after the end of the course of treatment with antibacterial/antifungal drugs.
- Avoid sexual intercourse for 3 days.
- Exclude douching and the use of vaginal...
Cheaper in a package